Increased Glucagon-Like Peptide-1 Secretion May Be Involved in Antidiabetic Effects of Ginsenosides

Journal of Endocrinology - United Kingdom
doi 10.1530/joe-12-0502
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Bioscientifica

Related search

Oleanolic Acid Derivative DKS26 Exerts Antidiabetic and Hepatoprotective Effects in Diabetic Mice and Promotes Glucagon-Like Peptide-1 Secretion and Expression in Intestinal Cells

British Journal of Pharmacology
Pharmacology
2017English

Cardiovascular and Hemodynamic Effects of Glucagon-Like Peptide-1

Reviews in Endocrine and Metabolic Disorders
EndocrinologyMetabolismDiabetes
2014English

Glucagon-Like Peptide 1 Shows Glucose Dependence in Regulating Islet Hormone Secretion

Metabolism: Clinical and Experimental
EndocrinologyMetabolismDiabetes
2020English

Glutamine Potently Stimulates Glucagon-Like Peptide-1 Secretion From GLUTag Cells

Diabetologia
Internal MedicineEndocrinologyMetabolismDiabetes
2004English

Effects of Gastric Inhibitory Polypeptide, Glucagon-Like Peptide-1 and Glucagon-Like Peptide-1 Receptor Agonists on Bone Cell Metabolism

Basic and Clinical Pharmacology and Toxicology
MedicineToxicologyPharmacology
2017English

Cardiovascular Effects of Glucagon-Like Peptide 1 (GLP-1) Receptor Agonists

Cardiovascular Diabetology
Internal MedicineCardiologyEndocrinologyCardiovascular MedicineMetabolismDiabetes
2014English

Glucagon-Like Peptide-1 Is Involved in Sodium and Water Homeostasis in Humans

Digestion
Gastroenterology
2006English

Gastric Bypass Surgery Enhances Glucagon-Like Peptide 1-Stimulated Postprandial Insulin Secretion in Humans

Diabetes
Internal MedicineEndocrinologyMetabolismDiabetes
2011English

Glucagon-Like Peptide-1 and Satiety

Nature
Multidisciplinary
1997English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy